4/A
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-25-049297
CEO acquired 30,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2025-01-30 | Option exercise 10b5-1 | +30,000 | $0.67 | $20,100 | 968,659 | D |
| Derivatives | |||||||
| Evans John M. CEO | 2025-01-30 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 69,336 | D | ||
Loading xslF345X05/ownership.xml…